Opus Therapeutics Inc

Tharimmune Inc. is a clinical-stage biotechnology company based in Chester, NJ, focused on developing a diverse portfolio of therapeutic candidates in immunology, inflammation, and oncology. Its lead clinical asset, TH104, is being advanced for specific indications related to respiratory and nervous system depression in military personnel and responders exposed to high-potency opioids. In addition to TH104, Tharimmune's expanded pipeline includes treatments for chronic pruritus in primary biliary cholangitis and TH023, a novel approach to autoimmune diseases. The company also leverages its proprietary EpiClick Technology to target unique epitopes against multiple solid tumors through an early-stage multispecific biologic platform. Generated from the website

MetasTx LLC is a clinical research company focused on developing innovative treatments for cancers that have a tendency to spread. With a commitment to scientific advancement, the company is dedicated to overcoming challenges in cancer treatment through rigorous research and due diligence. Located in Pittsburgh, PA, MetasTx LLC emphasizes a strategic approach to its scientific endeavors, comprising a knowledgeable team and a well-structured pipeline of research initiatives. The company aims to contribute significantly to the future of oncology by leveraging its scientific advantages in the battle against metastatic cancers. Generated from the website

Aerie Pharmaceuticals is a prominent ophthalmic pharmaceuticals company that specializes in researching and developing products for the treatment of glaucoma and various other eye diseases. With a focus on innovation and patient care, Aerie Pharmaceuticals is dedicated to advancing the field of ophthalmology through its cutting-edge research and development efforts. Generated from their website's infomation